Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules, manufactured by Sun Pharmaceuticals Ltd., is a specialized medication indicated for the treatment of blood cancer, offering targeted therapy to inhibit cancer cell growth.
Uses of Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules are used for:
Treatment of chronic myeloid leukemia (CML) in adults.
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and pediatric patients.
Benefits of Nilova (Nilotinib) 150mg Capsules
Targets and inhibits specific proteins responsible for the growth and survival of cancer cells.
Improves progression-free survival and overall survival rates in patients with CML and Ph+ ALL.
Offers a well-tolerated oral formulation, enhancing convenience and compliance with therapy.
Mechanism of Action of Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules contain nilotinib, a tyrosine kinase inhibitor that selectively inhibits BCR-ABL, c-KIT, and PDGFR kinases. By blocking these signaling pathways, nilotinib prevents the proliferation and survival of leukemia cells, leading to disease regression and improved clinical outcomes.
Beside this well also export in other countries